Use of the Serum Level of Cholinesterase as a Prognostic Marker of Nonfatal Clinical Outcomes in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease

<div>Correlation of the serum ChE level with hypercapnia (a), NIV requirement (b), hypoxemia severity (c), duration of hospital stay (d) and PH (e). ChE: cholinesterase, pCO<sub>2</sub>: partial pressure of carbon dioxide, NIV: noninvasive ventilation, OI: oxygenation index, and DoHS: duration of hospital stay.</div>

Canadian Respiratory Journal

fig3

Figure 3

Figure 3: Use of the Serum Level of Cholinesterase as a Prognostic Marker of Nonfatal Clinical Outcomes in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease 

Figure 3 | Use of the Serum Level of Cholinesterase as a Prognostic Marker of Nonfatal Clinical Outcomes in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease 